French Govt Has The Chance To Act Now To Boost Pharma Prospects, Says Industry Body
Executive Summary
Sales growth is slowing, innovation is being impaired, and prices remain constrained in France, says the industry body Leem. It has called on the government to take urgent action to remedy the situation.